CN Stock MarketDetailed Quotes

600624 Shanghai Fudan Forward S&T

Watchlist
  • 5.71
  • -0.63-9.94%
Not Open Nov 4 15:00 CST
3.91BMarket Cap-118958P/E (TTM)

About Shanghai Fudan Forward S&T Company

The company's predecessor was Fudan University Science and Technology Development Company founded in 1984. The company was restructured in June 1992 and listed on the Shanghai Stock Exchange in January 1993. It is the first listed company in colleges and universities in the country. The company's main business includes the three major business segments of pharmaceuticals, software, and parks. The company's main products are injectable glutathione, shuangyipine, flutamine tablets, isosorbide nitrate tablets, demand analysis, software development, operation and maintenance, rental of own housing, real estate development and operation, investment, consulting services, property management and supporting services. Corporate honors include “Shanghai Famous Trademark”, “Key Software Enterprise within the National Planning Layout”, and the second prize of the Shanghai Science and Technology Progress Award.

Company Profile

Short Name-A复旦复华
Symbol-A600624
Listing DateJan 5, 1993
Issue Price52.00
Shares Offered1.50M share(s)
FoundedNov 17, 1990
Listed ExchangeSH Stock Exchange
Legal Representativezheng song
General Managerzhengdai song
Secretarymin shen
Accounting FirmYongtuo Certified Public Accountants (Special General Partnership)
Securities Representativezhibin yu
Legal CounselBeijing Guantao Zhong Mao (Shanghai) Law Firm
Employees49
Phone021-63872288
Office Address525 Guoquan Road, Shanghai
Zip Code200433
Registered AddressRoom 107, Building 2, No. 1, Lane 1515, Huifeng North Road, Fengxian District, Shanghai
Fax021-63869700
Emailforward@forwardgroup.com
Business License310000000005918
BusinessDevelopment, production and sale of products such as computer systems, communication equipment, automated instruments, biotechnology, light source lighting, etc.; import and export business approved by the Commerce Commission; display of scientific and technological achievements; investment in production products and operations in other fields; “four technologies” and “three to one supplement” business.

Company Executives

  • Name
  • Position
  • Salary
  • zheng song
  • Chairman, Directors, Chairman of the Strategy Committee, Acting General Manager
  • 256.50K
  • jingyuan zhang
  • Directors
  • --
  • yan li
  • Directors, Nomination Committee Members
  • --
  • wei wang
  • Directors, Audit Committee Member
  • --
  • wei qian
  • Directors, Member of the Strategy Committee
  • --
  • yan lu
  • Directors
  • --
  • yongkang ren
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Member of the Strategy Committee, Audit Committee Member
  • 9.03K
  • wei ni
  • Independent Directors, Member of the Remuneration and Assessment Committee, Nomination Committee Members, Chairman of the Audit Committee
  • 9.03K
  • xianglei zhao
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
  • 9.03K
  • min shen
  • Board Secretary
  • 603.60K
  • zhibin yu
  • Securities Affairs Representative
  • --
  • leigang weng
  • Chairman of the Supervisory Board, Auditors
  • --
  • wei xu
  • Auditors
  • 668.00K
  • zhongwei shen
  • Auditors
  • --
  • zhongming jiang
  • Auditors
  • --
  • hangxiang fu
  • Deputy General Manager
  • 598.20K
  • chihao zhou
  • Deputy General Manager, Head of Finance
  • 1.00M
  • yue zhuang
  • Deputy General Manager
  • 877.20K
  • yuming chen
  • Deputy General Manager
  • 1.18M
  • qianqian ding
  • Employee Supervisors
  • 195.10K
  • haiyan qiang
  • Employee Supervisors
  • 165.70K
  • xinwei jiang
  • Employee Supervisors
  • 226.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data